Literature DB >> 9103679

TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation.

D Ron1.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9103679     DOI: 10.1007/978-3-642-60479-9_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  11 in total

1.  A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma.

Authors:  Taisuke Hosaka; Yasuaki Nakashima; Katsuyuki Kusuzaki; Hiroaki Murata; Tomitaka Nakayama; Takeharu Nakamata; Tomoki Aoyama; Takeshi Okamoto; Kohichi Nishijo; Nobuhito Araki; Tadao Tsuboyama; Takashi Nakamura; Junya Toguchida
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

Review 2.  Functional genomics of the murine immune system.

Authors:  H E Ruley
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.

Authors:  Angela Iervolino; Giorgia Santilli; Rossana Trotta; Clara Guerzoni; Vincenzo Cesi; Anna Bergamaschi; Carlo Gambacorti-Passerini; Bruno Calabretta; Danilo Perrotti
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.

Authors:  C R Antonescu; A Elahi; M Humphrey; M Y Lui; J H Healey; M F Brennan; J M Woodruff; S C Jhanwar; M Ladanyi
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

5.  BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway.

Authors:  D Perrotti; A Iervolino; V Cesi; M Cirinná; S Lombardini; E Grassilli; S Bonatti; P P Claudio; B Calabretta
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.

Authors:  Katarina Engström; Helena Willén; Christina Kåbjörn-Gustafsson; Carola Andersson; Marita Olsson; Melker Göransson; Sofia Järnum; Anita Olofsson; Elisabeth Warnhammar; Pierre Aman
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.

Authors:  D Perrotti; S Bonatti; R Trotta; R Martinez; T Skorski; P Salomoni; E Grassilli; R V Lozzo; D R Cooper; B Calabretta
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

8.  Structure of noncoding RNA is a determinant of function of RNA binding proteins in transcriptional regulation.

Authors:  Takanori Oyoshi; Riki Kurokawa
Journal:  Cell Biosci       Date:  2012-01-03       Impact factor: 7.133

9.  Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.

Authors:  S-M Oh; Z Liu; M Okada; S-W Jang; X Liu; C-B Chan; H Luo; K Ye
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

10.  Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription.

Authors:  Xiangting Wang; Shigeki Arai; Xiaoyuan Song; Donna Reichart; Kun Du; Gabriel Pascual; Paul Tempst; Michael G Rosenfeld; Christopher K Glass; Riki Kurokawa
Journal:  Nature       Date:  2008-05-28       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.